To deepen their presence in the TCM extraction field and promote high-quality development of the industry, StarHealth and Alps Pharmaceutical Ind. Co., Ltd. have further strengthened their strategic partnership by establishing the joint venture ChenFei Kampo Pharmaceutical Co., Ltd and building a modern raw-material extraction plant for TCM preparations in Anguo, Hebei Province. This will create a new China-Japan collaboration channel for TCM extraction industry.
Positioned for standardized production, the new plant will own a core production capacity of 350 metric tons of TCM extracts per year. All products will strictly meet Japanese pharmaceutical raw-material quality standards. The construction has recently commenced and is scheduled for completion in the autumn of 2026.
Alps Pharmaceutical Ind. Co., Ltd. is a leader in Japan’s Kampo extracts field, possessing the industry-leading production technology and refined management experience, and enjoys exceptionally high brand recognition in the Japanese market. StarHealth, based on her abundant botanical raw-material resources, a mature supply chain and a complete quality management system, holds distinctive competitive advantages in supply of botanical raw materials to global market.
This joint venture and plant construction represent deep integration between Chinese and Japanese enterprises in the TCM extraction field. In future, two parties will fully combine their core strengths in technology, resources and market, striving to build ChenFei Kampo Pharmaceutical Co., Ltd into an industry benchmark for TCM extraction and push TCM extraction industry continuously forward.
